biospecimen__admin__batch_number	303.59.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	B22339E8-E33D-4C34-B7AE-4A3016FBA494
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A4NQ-01A-21R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A4NQ-01A-21
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A4NQ-01A
biospecimen__bio__biospecimen_barcode_bottom	0132269965
biospecimen__bio__day_of_creation	05
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-DD-A4NQ.D79DB738-2DA3-43F6-898C-4A212964FA03.pdf
biospecimen__bio__plate_column	11
biospecimen__bio__plate_id	A28Z
biospecimen__bio__plate_row	G
biospecimen__bio__portion_sequence	2
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2012
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A4NQ
biospecimen__shared__patient_id	A4NQ
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A4NQ-A43378
clinical__ablation__bcr_ablation_uuid	73A0E12B-2408-4494-9858-C79A32E695B3
clinical__ablation__days_to_embolization_performed	211
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_type	Radioembolization
clinical__ablation__embolizing_agent_utilized	Y-90 Therasphere
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	6A3633DB-848E-4D67-800D-61B3E2BD6474
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.4
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	141
clinical__chol_lihc_shared__hist_hepato_carc_fact	Other
clinical__chol_lihc_shared__hist_hepato_carcinoma_risk	tobacco
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12.0
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.1
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	Macro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	60
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A4NQ-F49669
clinical__clin_shared__bcr_followup_uuid	BB6C349B-C1A3-452F-BE57-D007A52948ED
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	20
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	283
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	HBV Surface Antibody
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2007
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	126
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-DD-A4NQ-D43379
clinical__rx__bcr_drug_uuid	AF94B879-0ED7-4F2A-A418-B3B3C6DA6FA0
clinical__rx__days_to_drug_therapy_end	290
clinical__rx__days_to_drug_therapy_start	151
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	deba7ff8-66f8-4876-a23f-0040b771a91d
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A4NQ-01A-21R-A28Z-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	7c030952-bb47-47aa-be2d-fe209378a70a
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.88
gdc__analytes__analyte_id	921b4a58-b7a6-4ee8-9e6d-c87128d9b40a
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	c05720fe-19c1-4cff-819b-6806b26fc312
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:37:39.749293-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	f77358eb-e564-5beb-888b-7799e6026ae8
gdc__demographic__ethnicity	hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1947
gdc__demographic__year_of_death	2008
gdc__diagnoses__age_at_diagnosis	22111
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-22111.0
gdc__diagnoses__days_to_death	373.0
gdc__diagnoses__diagnosis_id	61e04137-c475-598d-8df4-878cee88a0da
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	29.666548000474663
gdc__exposures__exposure_id	2731c752-83dc-5f18-86d8-718a37d9e55b
gdc__exposures__height	159.0
gdc__exposures__weight	75.0
gdc__file_id	74026969-eab8-44f1-8746-d89d5a450ba1
gdc__file_name	45da1c01-0316-4dbf-939b-4a758fd7e5e7.mirbase21.mirnas.quantification.txt
gdc__file_size	50294
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	f20d3488568b2446f558fd50e0f9e7c4
gdc__portions__is_ffpe	false
gdc__portions__portion_id	aa4fb10c-bc9d-4afd-996a-066ab9cb02fa
gdc__portions__portion_number	21
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	2030
gdc__samples__initial_weight	120.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	D79DB738-2DA3-43F6-898C-4A212964FA03
gdc__samples__sample_id	1e18c64b-42c7-424b-bd32-a1e7797f28a7
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	20.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	80.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	749127ce-a199-4f29-a3a1-353c631fd161
gdc__submitter_id	mirna_swap_dr11_253_MirnaExpressiondb3753f8-7138-44ae-bf1d-be278436b4ee_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	526e6e48-680a-525e-a053-cdb711230c7e
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:34.655+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/deba7ff8-66f8-4876-a23f-0040b771a91d-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/deba7ff8-66f8-4876-a23f-0040b771a91d-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129665
manually_curated__local_md5	76713343718c5a5179aebc857ac9a967
manually_curated__opengdc_download_date	2018-10-16T17:12:03.000663+02:00
manually_curated__opengdc_file_md5	4ce65f34da6335d9c4b463b89f3b6b6d
manually_curated__opengdc_file_size	50293
manually_curated__opengdc_id	deba7ff8-66f8-4876-a23f-0040b771a91d-meq
manually_curated__origin_file_size	129665
manually_curated__origin_last_modified_date	Tue Oct 16 18:04:00 CEST 2018
manually_curated__origin_md5	76713343718c5a5179aebc857ac9a967
manually_curated__tissue_status	tumoral
